About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Philadelphia | 362 Studies

Clinical Trials Prostate CancerPhiladelphia

Prostate Cancer Clinical Trials in Philadelphia

Find 362 clinical trials for prostate cancer near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-180 of 362 trials

TerminatedSafety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid TumorsThe purpose of this study is to evaluate the safety and activity of BPX-601 CAR-T cells in participants with previously treated advanced solid tumors (prostate) expressing high…NCT02744287·Tampa, Florida and 12 others TerminatedInitiative to Minimize Disparities in Postoperative Prostate Cancer CareEinstein Healthcare Network in North Philadelphia serves a predominantly underserved medical community.NCT03755492·Philadelphia, Pennsylvania Active not recruitingStudy of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)This study will assess the efficacy and safety of capivasertib plus docetaxel versus placebo plus docetaxel in participants with metastatic castration resistant prostate cancer…NCT05348577·Yuma, Arizona and 216 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer PatientsRADICAL PC1 is a prospective cohort study of men with a new diagnosis of prostate cancer.NCT03127631·Augusta, Georgia and 60 others

CompletedTreatment Preference and Patient Centered Prostate Cancer CareThe purpose of this study is to develop a preference based decision aid to assess the treatment preferences of prostate cancer patients, and to analyze the interaction of…NCT02032550·Philadelphia, Pennsylvania and 2 others

CompletedSamarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate CancerRATIONALE: Giving samarium Sm 153 lexidronam pentasodium and 3-dimensional (3-D) conformal radiation therapy or intensity-modulated radiation therapy may keep prostate cancer from…NCT00551525·Phoenix, Arizona and 28 others

Active not recruitingPhase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerThe purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized…NCT01436968·Gilbert, Arizona and 72 others

CompletedHormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate CancerRATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00004054·Birmingham, Alabama and 53 others

RecruitingTesting the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE TrialThis phase III trial compares the effect of adding docetaxel to hormonal therapy and apalutamide versus hormonal therapy and apalutamide alone in treating patients with prostate…NCT06931340·Tucson, Arizona and 212 others

CompletedA Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate CancerThis study is being done to evaluate the safety and efficacy of atrasentan in men with metastatic hormone-refractory prostate cancer.NCT00036543·Homewood, Alabama and 231 others

CompletedA Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate CancerThis study will ascertain the feasibility and effect of Eischens yoga interventions on radiation related fatigue, sexual dysfunction and urinary incontinence in stage I /II…NCT02135653·Philadelphia, Pennsylvania

RecruitingFirst-Time-in-Human Study of GSK5471713 in Adults With mCRPCThis first-time-in-human study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, preliminary clinical activity, and establish the benefit/risk of…NCT07332455·La Jolla, California and 15 others

TerminatedMitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)The purpose of this research study is to determine if the combination of mitoxantrone, prednisone and sorafenib will improve the time to progression of advanced stage metastatic…NCT00452387·La Verne, California and 9 others

CompletedMagnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate CancerRATIONALE: Imaging procedures such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) may improve the ability to detect the extent of prostate…NCT00032058·San Francisco, California and 7 others

TerminatedDose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate CancerThis study aims to evaluate the combination of GSK525762 with other agents that have been shown to be effective in the treatment of CRPC or metastatic (m)CRPC.NCT03150056·Los Angeles, California and 19 others

TerminatedExpanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)The SPERA trial is designed to 1. provide satraplatin to physicians with patients who have hormone refractory prostate cancer (HRPC) which has progressed following unlimited…NCT00450970·Birmingham, Alabama and 120 others

CompletedHyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After RadiationThis phase I trial studies the side effects and best way to give hyperthermia and high dose rate radiation therapy in treating patients with prostate cancer that has come back…NCT02899221·Philadelphia, Pennsylvania

CompletedIntensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00084552·Philadelphia, Pennsylvania

Active not recruitingGenomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate CancerThis study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also developing a pragmatic approach for improved GEC…NCT04396808·Ann Arbor, Michigan and 7 others

Completed18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer TreatmentThis prospective study will enroll up to 330 men with PSA-persistent or PSA-recurrent prostate cancer after curative-intent primary therapy and negative or equivocal findings on…NCT02680041·Duarte, California and 16 others

PreviousPage 9 of 19Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma